[1]
Munshi, R. et al. 2025. Association of hyperglycemia with Tenofovir+Lamivudine+Dolutegravir (TLD) or Tenofovir+Lamivudine+Efavirenz (TLE) antiretroviral regimens in patients living with HIV: a retrospective cohort study. The Nigerian Health Journal. 25, 2 (Jun. 2025), 561–569. DOI:https://doi.org/10.71637/tnhj.v25i2.949.